These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 10090941

  • 1. Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway.
    Kolenko V, Rayman P, Roy B, Cathcart MK, O'Shea J, Tubbs R, Rybicki L, Bukowski R, Finke J.
    Blood; 1999 Apr 01; 93(7):2308-18. PubMed ID: 10090941
    [Abstract] [Full Text] [Related]

  • 2. Forskolin-inducible cAMP pathway negatively regulates T-cell proliferation by uncoupling the interleukin-2 receptor complex.
    Rodriguez G, Ross JA, Nagy ZS, Kirken RA.
    J Biol Chem; 2013 Mar 08; 288(10):7137-46. PubMed ID: 23341462
    [Abstract] [Full Text] [Related]

  • 3. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
    Kolenko V, Wang Q, Riedy MC, O'Shea J, Ritz J, Cathcart MK, Rayman P, Tubbs R, Edinger M, Novick A, Bukowski R, Finke J.
    J Immunol; 1997 Sep 15; 159(6):3057-67. PubMed ID: 9300731
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway.
    Borger P, Kauffman HF, Postma DS, Vellenga E.
    Blood; 1996 Jan 15; 87(2):691-8. PubMed ID: 8555492
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the 3',5'-cyclic adenosine monophosphate-mediated regulation of IL2 production by T cells and Jurkat cells.
    Wacholtz MC, Minakuchi R, Lipsky PE.
    Cell Immunol; 1991 Jul 15; 135(2):285-98. PubMed ID: 1709824
    [Abstract] [Full Text] [Related]

  • 6. Adenosine 3',5'-cyclic monophosphate (cAMP) inhibits phorbol ester-induced growth of an IL-2-dependent T cell line.
    Goto Y, Takeshita T, Sugamura K.
    FEBS Lett; 1988 Nov 07; 239(2):165-8. PubMed ID: 2460372
    [Abstract] [Full Text] [Related]

  • 7. Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3',5'-monophosphate and phosphatases.
    Zhang H, Conrad DM, Butler JJ, Zhao C, Blay J, Hoskin DW.
    J Immunol; 2004 Jul 15; 173(2):932-44. PubMed ID: 15240680
    [Abstract] [Full Text] [Related]

  • 8. Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways.
    Paliogianni F, Kincaid RL, Boumpas DT.
    J Exp Med; 1993 Nov 01; 178(5):1813-7. PubMed ID: 7693857
    [Abstract] [Full Text] [Related]

  • 9. Activation of the cAMP-dependent signaling pathway downregulates the expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor in activated human T lymphocytes.
    Borger P, Kauffman HF, Vijgen JL, Postma DS, Vellenga E.
    Exp Hematol; 1996 Feb 01; 24(2):108-15. PubMed ID: 8641331
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
    Tamir A, Granot Y, Isakov N.
    J Immunol; 1996 Aug 15; 157(4):1514-22. PubMed ID: 8759733
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells.
    Rincón M, Tugores A, López-Rivas A, Silva A, Alonso M, De Landázuri MO, López-Botet M.
    Eur J Immunol; 1988 Nov 15; 18(11):1791-6. PubMed ID: 2849551
    [Abstract] [Full Text] [Related]

  • 12. cAMP is not involved in interleukin-1-induced interleukin-6 release from human astrocytoma cells.
    Cadman ED, Naugles DD, Lee CM.
    Neurosci Lett; 1994 Sep 12; 178(2):251-4. PubMed ID: 7529912
    [Abstract] [Full Text] [Related]

  • 13. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
    Bartik MM, Bauman GP, Brooks WH, Roszman TL.
    Cell Immunol; 1994 Oct 01; 158(1):116-30. PubMed ID: 8087859
    [Abstract] [Full Text] [Related]

  • 14. Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation.
    Zhou YJ, Magnuson KS, Cheng TP, Gadina M, Frucht DM, Galon J, Candotti F, Geahlen RL, Changelian PS, O'Shea JJ.
    Mol Cell Biol; 2000 Jun 01; 20(12):4371-80. PubMed ID: 10825200
    [Abstract] [Full Text] [Related]

  • 15. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain.
    Kirken RA, Rui H, Malabarba MG, Howard OM, Kawamura M, O'Shea JJ, Farrar WL.
    Cytokine; 1995 Oct 01; 7(7):689-700. PubMed ID: 8580378
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells.
    Sheibanie AF, Tadmori I, Jing H, Vassiliou E, Ganea D.
    FASEB J; 2004 Aug 01; 18(11):1318-20. PubMed ID: 15180965
    [Abstract] [Full Text] [Related]

  • 17. Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction.
    Kawahara A, Minami Y, Miyazaki T, Ihle JN, Taniguchi T.
    Proc Natl Acad Sci U S A; 1995 Sep 12; 92(19):8724-8. PubMed ID: 7568005
    [Abstract] [Full Text] [Related]

  • 18. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels.
    Anastassiou ED, Paliogianni F, Balow JP, Yamada H, Boumpas DT.
    J Immunol; 1992 May 01; 148(9):2845-52. PubMed ID: 1374102
    [Abstract] [Full Text] [Related]

  • 19. Activation of interleukin-2 receptor gene by forskolin and cyclic AMP analogues.
    Narumiya S, Hirata M, Nanba T, Nikaido T, Taniguchi Y, Tagaya Y, Okada M, Mitsuya H, Yodoi J.
    Biochem Biophys Res Commun; 1987 Mar 13; 143(2):753-60. PubMed ID: 3032178
    [Abstract] [Full Text] [Related]

  • 20. Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells.
    Nukaga J, Kobayashi M, Shinki T, Song H, Takada T, Takiguchi T, Kamijo R, Hasegawa K.
    J Periodontol; 2004 Feb 13; 75(2):249-59. PubMed ID: 15068113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.